VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Understanding Yutian Medical Shanghai Deal

<< Previous

Bullboard Posts

Next >>

Comment by woundedkneeon Mar 04, 2021 9:16am

107 Views

Post# 32713448

RE:RE:RE:RE:Understanding Yutian Medical Shanghai Deal

Don't mention PYR to me. I was in it for three years and it never got above 30 cents. After I exited at 20 cents..well you know the rest of the story.
Yes I agree, this does indeed have the potential for terrific future earnings. The key word is future and I for one do not mind buying back at a higher price. And I get it...its nice to have a 20 bagger rather than a five or ten bagger. I would sooner have the latter when I feel the risk has been reduced. Thanks for the civil response and I respect your views.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity